The FDA approved the Medtronic MiniMed 530G insulin pump with its display of the Enlite continuous glucose monitor in September, 2013. The 530G is the first system in the United States that can automatically stop insulin delivery if the CGM's glucose value falls to a preset level (60-90 mg/dl) AND the wearer doesn't respond to the Threshold Suspend Alarm. This functionality puts the device in the newly created OZO: Artificial Pancreas Device Classification created by the U.S. Food and Drug Administration.
The Animas Vibe is an insulin pump with a built in Dexcom Continuous Glucose Monitor. Although there is a pump-only version of the Vibe available, the combination of the pump and monitor are what makes the Vibe stand out. The Vibe, alone, is basically the Animas 2020 pump platform from a few years ago.
The Vibe has been available in the UK since 2011. Johnson & Johnson finally submitted the Animas Vibe to the FDA in April of 2013.
The APP Study was conducted to see how people who have good control really use their pumps and to find what settings give the best glucose results. We analyzed anonymous data from several hundred Deltec Cozmo insulin pumps (Smiths Medical) that were consecutively downloaded during a large, routine software upgrade of all Cozmo pumps in 2007. The pumps were prescribed and used around the U.S. by a wide variety of clinicians and wearers. Insulin dosing was analyzed from a subset of 396 pumps where glucose readings were directly entered from an attached meter.
A built-in bolus calculator uses personalized settings to make bolus doses more accurate and less likely to cause insulin stacking from prior boluses. The pump bolus calculator allows bolus recommendations to match the carbs you eat, bring down high readings, and minimize insulin stacking. For optimal glucose results, these bolus calculator settings are adjusted:
When choosing a pump, take the time you need to make a good choice. You will depend on this pump for 4 to 5 years, so discuss different pumps and pump options with your doctor and health care team to select the features that will be most helpful. Be sure to take a look at our Pump Comparison Page to help with your pump choice.
A pump offers convenience, more consistent insulin action from day to day, easier problem solving, easier tracking of insulin use, less hypoglycemia, less risk of hypoglycemia unawareness, and fewer morning and post-meal highs. These conveniences come from specific features that are standard in most pumps. Training is required to benefit from all the pump features listed below.
At the 72nd Scientific Sessions of the American Diabetes Association, Tandem announced that it will begin accepting orders for the t:slim™ Insulin Delivery System, the first insulin pump approved by the FDA with a touch screen, on Monday, June 11, 2012 starting at 6:00am. The product will begin shipping in August 2012.
Full press release is below.